OOIR: Observatory of International Research

Papers

(The H4-Index of Vaccine is 66. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?	801
Evidence for antibody as a protective correlate for COVID-19 vaccines	740
Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic	475
Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey	468
Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England	387
Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong	358
International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples	351
Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional surv	319
Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey	258
mRNA vaccines manufacturing: Challenges and bottlenecks	227
Human monkeypox – After 40 years, an unintended consequence of smallpox eradication	206
Myocarditis following COVID-19 mRNA vaccination	202
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge	187
A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine	180
Vaccine hesitancy and perceived behavioral control: A meta-analysis	179
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data	170
Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia	147
The public’s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States	144
Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: An analysis of provincial electronic immunization registry data	141
Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis	138
Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis	137
The disease burden of influenza beyond respiratory illness	136
Individual preferences for COVID-19 vaccination in China	135
COVID-19 vaccine intentions in the United States, a social-ecological framework	129
Social norms and vaccine uptake: College students’ COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine	121

Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US	117
Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study	117
Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)	116
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018	116
Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial	113
Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions	113
Prenatal maternal COVID-19 vaccination and pregnancy outcomes	110
Towards a population-based threshold of protection for COVID-19 vaccines	108
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization	107
Arboviruses: A global public health threat	106
The demand for a COVID-19 vaccine in Ecuador	105
The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization	103
Contingent assessment of the COVID-19 vaccine	102
Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia	101
Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response	101
Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines	100
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis	96
Timing of COVID-19 vaccine approval and endorsement by public figures	96
Preferences for a COVID-19 vaccine in Australia	95
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults	88
Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia	87
COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization	84
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches	84
An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic	83
Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-indu	83
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis	81
Christian nationalism and COVID-19 vaccine hesitancy and uptake	79
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models	78
COVID-19 vaccine – Long term immune decline and breakthrough infections	78
Vaccination against coronaviruses in domestic animals	76
Public attitudes toward COVID-19 vaccines on English-language Twitter: A sentiment analysis	76
Influenza immunization and COVID-19	74
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis	73
Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use	72
Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis	71
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization	70
The need for inclusion of pregnant women in COVID-19 vaccine trials	69
Predicting COVID-19 vaccination intention using protection motivation theory and conspiracy beliefs	67
Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake	66
Prophylactic HPV vaccination after conization: A systematic review and meta-analysis	66
Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies	66